Want to join the conversation?
$LH's LabCorp Diagnostics is expected to grow 4.5-5.5% in 2015, after the impact of about 90 basis points of negative currency. This is an increase from prior guidance of 3.5-5.5%, mainly due to continued strong organic growth. Covance Drug Development revenue is expected to be in the range of -0.5% to 0.5% versus 2014.
$DB is going to cut off services for about 3,400 clients in equities trading.
$F stock slid more than 2% after the company issued two safety recalls involving more than 650,000 Ford Fusion and Lincoln MKZ model cars.
The new CEO of $SBUX, Kevin Johnson, has some pretty large shoes to fill but there are many who have good faith in his ability to do so.
$TSLA opening a showroom in Michigan. A bold move !!